Lv13
28 积分 2025-03-04 加入
Sorafenib in advanced hepatocellular carcinoma
42分钟前
已完结
Global Epidemiology and Genetics of Hepatocellular Carcinoma
1天前
已完结
Conversion surgery as a missing outcome in first-line immunotherapy trials for hepatocellular carcinoma
1个月前
已关闭
The use of advanced machine learning to predict outcomes after atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: a retrospective cohort study
1个月前
已完结
Coagulation parameters and major bleeding in critically ill patients with cirrhosis
1个月前
已完结
Assessment of bleeding in chronic liver disease and coagulopathy using the IMPROVE bleeding criteria
1个月前
已完结
Validation of the International Medical Prevention Registry on Venous Thromboembolism Bleeding Risk Score
1个月前
已完结
Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Biomarker in Advanced Hepatocellular Carcinoma Treated with First-Line Immunotherapy
2个月前
已完结
ongterm outcome of hepatectomy following conversion therapy for initially unresectable hepatocellular carcinoma versus direct hepatectomy for early-stage hepatocellular carcinoma
3个月前
已完结
皖公网安备34019202002308
